🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Drug Dose

GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer NCT07489287Phase 11 site📍 Buffalo Roswell Park Cancer Institute · Tests: GB-5267 - IV only, GB-5267 -Combined IV and IP Infusion A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors NCT05615974Phase 1, Phase 25 sites📍 Guangzhou📍 Wuhan📍 Linyi LaNova Medicines Limited · Tests: LM101, Toripalimab, Rituximab Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors NCT04222413Phase 12 sites📍 Fairway📍 Bethesda National Cancer Institute (NCI) · Tests: Metarrestin A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function NCT07315360Phase 14 sites📍 Lake Forest📍 Orlando📍 Tampa Pfizer · Tests: PF-07328948 A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs NCT06908928Phase 17 sites📍 Duarte📍 La Jolla📍 Aurora Mabwell (Shanghai) Bioscience Co., Ltd. · Tests: bulumtatug fuvedotin, bulumtatug fuvedotin Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors NCT06724016Phase 17 sites📍 Boston📍 Detroit📍 Seongnam-si Hanmi Pharmaceutical Company Limited · Tests: HM16390, pembrolizumab TT-702 in Patients With Advanced Solid Tumours. NCT05272709Phase 1, Phase 23 sites📍 London📍 Manchester📍 Southampton Cancer Research UK · Tests: TT-702, Anti-PD-1 and PD-L1 agent A Phase 1 Study of Single and Multiple Ascending Doses of GV-100 NCT07788014Phase 11 site📍 Adelaide Gilva Therapeutics Inc. · Tests: GV-100, Placebo A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors NCT06126666Phase 13 sites📍 Seongnam📍 Seoul📍 Seoul ABL Bio, Inc. · Tests: ABL103 A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors NCT07318805Phase 113 sites📍 Duarte📍 Grand Rapids📍 Long Island City Pfizer · Tests: PF-08032562, Fulvestrant, Cetuximab, Fluorouracil, Oxaliplatin IKS014 in Advanced Solid Tumors That Express HER2 NCT05872295Phase 113 sites📍 Newport Beach📍 Boston📍 Nashville Iksuda Therapeutics Ltd. · Tests: IKS014 Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients NCT05410275Phase 32 sites📍 Tours📍 Tours University Hospital, Tours · Tests: Rivaroxaban GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors NCT04977453Phase 1, Phase 213 sites📍 New York📍 New York📍 Huntersville GI Innovation, Inc. · Tests: GI-101, Pembrolizumab (KEYTRUDA®), Lenvatinib, GI-101A Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer NCT06287775Phase 1, Phase 243 sites📍 Duarte📍 Irvine📍 La Jolla National Cancer Institute (NCI) · Tests: Atezolizumab, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Durvalumab Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia NCT07109219Phase 1, Phase 227 sites📍 Duarte📍 Jacksonville📍 Chicago AstraZeneca · Tests: AZD4512 monotherapy Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors NCT06086522Phase 14 sites📍 Scottsdale📍 New Haven📍 Grand Rapids Qualigen Theraputics, Inc. · Tests: QN-302 A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours NCT06868199Phase 1, Phase 26 sites📍 Ryde📍 Ryde📍 Wollongong LaNova Medicines Limited · Tests: LM-168, Toripalimab A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IMV101 as a Single Agent in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma NCT07376642EARLY Phase 14 sites📍 Beijing📍 Beijing📍 Zhengzhou Suzhou Immunofoco Biotechnology Co., Ltd · Tests: IMV101 treatment A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function NCT07269301Phase 13 sites📍 Lake Forest📍 Orlando📍 Tampa Pfizer · Tests: PF-07328948 Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling NCT05431257Phase 21 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: Venetoclax ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB) NCT07741461Phase 11 site📍 Shanghai Xiamen Amoytop Biotech Co., Ltd. · Tests: ACT201 Injection, ACT201 Injection Placebo Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS) NCT05114096Phase 425 sites📍 Calgary📍 Edmonton📍 New Westminster McMaster University · Tests: Celestone + placebo, Celestone + Celestone Southeast Asia Dose Optimization of Tafenoquine NCT04704999Phase 46 sites📍 Siem Reap📍 Jayapura📍 Vientiane University of Oxford · Tests: Tafenoquine, Chloroquine, Artemether 20 mg-Lumefantrine 120 mg, Primaquine, Dihydroartemisinin 40 mg-Piperaquine 320 mg Analgesic Efficacy of Different Liposomal Bupivacaine Doses in the Adductor Canal Block for Total Knee Arthroplasty NCT06740214Phase 31 site📍 Hong Kong The University of Hong Kong · Tests: 0.5% standard bupivacaine only, 1.33% liposomal bupivacaine with 0.5% standard bupivacaine, 1.33% liposomal bupivacaine… A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity NCT07566390Phase 12 sites📍 Glendale📍 Baltimore Novo Nordisk A/S · Tests: NNC0113-5840, Placebo A Phase 1 Study of LNCB74 in Advanced Solid Tumors NCT06774963Phase 114 sites📍 Newport Beach📍 Edgewood📍 Boston NextCure, Inc. · Tests: LNCB74 A Study to See How Safe a New Medicine (NNC0705-0002) is in Healthy People NCT07797855Phase 11 site📍 Groningen Novo Nordisk A/S · Tests: NNC0705-0002, Placebo Safety, Tolerability, and Pharmacokinetic Profile of Grammidin With Anesthetic, a Metered Dose Topical Spray in Healthy Volunteers NCT06857890Phase 11 site📍 Moscow Valenta Pharm JSC · Tests: Grammidin with anesthetic neo, Grammidin with anesthetic, a metered dose topical spray High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors NCT06418789Phase 21 site📍 Saint Petersburg N.N. Petrov National Medical Research Center of Oncology · Tests: High-dose chemotherapy (TI- 2 cycles, CE- 3 cycles ) A Study of Zasocitinib in Adults With Nonsegmental Vitiligo NCT07108283Phase 269 sites📍 Bryant📍 Fountain Valley📍 Fremont Takeda · Tests: Zasocitinib, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy